AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Casonato, A Pontara, E Sartorello, F Gemmati, D Cattini, MG Girolami, A
Citation: A. Casonato et al., Combined hemophilia A and type 2N von Willebrand's disease: defect of bothfactor VIII level and factor VIII binding capacity of von Willebrand factor, HAEMATOLOG, 86(10), 2001, pp. 1110-1111

Authors: Gemmati, D Serino, ML Ongaro, A Tognazzo, S Moratelli, S Resca, R Moretti, M Scapoli, GL
Citation: D. Gemmati et al., A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases, AM J HEMAT, 67(3), 2001, pp. 183-188

Authors: Hoekema, L Castoldi, E Tans, G Girelli, D Gemmati, D Bernardi, F Rosing, J
Citation: L. Hoekema et al., Functional properties of factor V and factor Va encoded by the R2-gene, THROMB HAEM, 85(1), 2001, pp. 75-81

Authors: Gemmati, D Previati, M Serino, ML Moratelli, S Guerra, S Capitani, S Forini, E Ballerini, G Scapoli, GL
Citation: D. Gemmati et al., Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects, ART THROM V, 19(7), 1999, pp. 1761-1767

Authors: Gemmati, D Serino, ML Trivellato, C Fiorini, S Scapoli, GL
Citation: D. Gemmati et al., C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients, HAEMATOLOG, 84(9), 1999, pp. 824-828

Authors: Moratelli, S De Sanctis, V Gemmati, D Serino, ML Mari, R Gamberini, MR Scapoli, GL
Citation: S. Moratelli et al., Thrombotic risk in thalassemic patients, J PED END M, 11, 1998, pp. 915-921

Authors: Bernardi, F Casonato, A Marchetti, G Gemmati, D Bizzaro, N Pontara, E Girolami, A
Citation: F. Bernardi et al., Two novel mutations (Pro864His, Va1867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28, BR J HAEM, 103(3), 1998, pp. 885-887
Risultati: 1-7 |